CALZF (Polynovo) Moat Score: 5/10 (As of Jun. 30, 2026)


CALZF Polynovo Ltd CALZF
75 GF Score
Price $0.62
GF Value $2.21
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Polynovo Moat Score?

Polynovo CALZF 75 Moat Score is 5 as of Jun. 30, 2026. GuruFocus rates CALZF with a GF Score™ of 75/100 and a GF Value™ of $2.21 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Polynovo ranks better than 91.25% on this metric.

Polynovo has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Polynovo has Narrow Moat: Polynovo Ltd has valuable intellectual property in the medical device sector, with innovative R&D capabilities. It holds a solid position due to its proprietary technology, but faces competition and lacks significant regulatory barriers to ensure a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Polynovo might have Narrow Moat - Solid narrow moat.

Polynovo  (OTCPK:CALZF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Polynovo Moat Score Related Terms

CALZF vs ABT, SYK, MDT: Moat Score Comparison

For the Medical Devices subindustry, Polynovo's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polynovo Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polynovo's Moat Score distribution charts can be found below:

* The bar in red indicates where Polynovo's Moat Score falls into.


CALZF
75GF Score
Polynovo Ltd CALZF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Polynovo (CALZF) has a Moat Score of 5 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Polynovo ranks #74 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 8.7%.
Is Polynovo's Moat Score too high?
Polynovo's current Moat Score is 5. Based on the distribution chart, Polynovo ranks #74 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Polynovo has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Polynovo's Moat Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Polynovo ranks #74 out of 846 companies for Moat Score. This places Polynovo in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Polynovo's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polynovo stock overvalued right now?
Based on GuruFocus' analysis, Polynovo (CALZF) is currently considered Significantly Undervalued. The stock's GF Value™ is $2.21, compared to a current price of $0.62 — trading 71.9% below its estimated fair value. The current Moat Score is 5. Polynovo's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Polynovo (CALZF), the current Moat Score is 5 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polynovo (CALZF) Overvalued in 2026?

Based on GuruFocus' analysis, Polynovo stock appears to be undervalued. The current stock price of $0.62 is trading 71.9% below its estimated GF Value™ of $2.21. GuruFocus considers Polynovo to be Significantly Undervalued.

Key valuation signals for CALZF:

  • Moat Score: 5
  • GF Value™: $2.21 vs. price of $0.62 (71.9% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the CALZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Polynovo Business Description

Other Exchanges MFJ:GermanyPNV:Australia
Address 320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.
75GF Score

Get the complete analysis for CALZF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.62
Price
$2.21
GF Value